Agilent Technologies Inc vs Global Payments Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Global Payments Inc trades at $86.06 (market cap $22.79B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Global Payments Inc pays the higher dividend (1.16%). Which is the better fit depends on your goals.
| A | GPN | |
|---|---|---|
Market Cap | $42.00B | $22.79B |
Sector | Health | Industrials |
52-Week High | $157.20 | $90.01 |
52-Week Low | $110.24 | $62.47 |
Enterprise Value | $43.55B | $40.94B |
Dividend Yield | 0.69% | 1.16% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Global Payments (GPN) trades at $86.12, down 1.79% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability margins and positive cash flow, though net income margin and ROE are negative. Recent news highlights Q2 2026 earnings exceeding expectations, driven by Genius platform growth, despite revenue guidance adjustments.
Outlook remains supported by analyst consensus with a $96.67 price target, but risks include margin pressure from rising costs and competitive fintech threats. The stock offers upside potential if execution continues, but investors should monitor debt levels and macroeconomic impacts on payment volumes.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →